Cargando…
Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer
Circulating tumor DNA (ctDNA) analysis has the potential to allow non-invasive analysis of tumor mutations in advanced cancer. In this study we assessed the reproducibility of digital PCR (dPCR) assays of circulating tumor DNA in a cohort of patients with advanced breast cancer and assessed delayed...
Autores principales: | Hrebien, Sarah, O’Leary, Ben, Beaney, Matthew, Schiavon, Gaia, Fribbens, Charlotte, Bhambra, Amarjit, Johnson, Richard, Garcia-Murillas, Isaac, Turner, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070760/ https://www.ncbi.nlm.nih.gov/pubmed/27760227 http://dx.doi.org/10.1371/journal.pone.0165023 |
Ejemplares similares
-
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
por: O’Leary, Ben, et al.
Publicado: (2018) -
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer
por: O’Leary, Ben, et al.
Publicado: (2020) -
Determination of HER2 Amplification Status on Tumour DNA by Digital PCR
por: Garcia-Murillas, Isaac, et al.
Publicado: (2013) -
Genomic profile of advanced breast cancer in circulating tumour DNA
por: Kingston, Belinda, et al.
Publicado: (2021) -
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA
por: Kingston, Belinda, et al.
Publicado: (2021)